Replacing two cycles of intensive chemotherapy with Blincyto raised four-year event-free survival to 83% from 70.3% in children with high-risk B-cell ALL, with far fewer infections.
|Podcasts|April 25, 2019
Focusing on Adolescent and Young Adult Cancer
Author(s)Kristie L. Kahl
In this week’s episode, we spoke with a young adult and a child life specialist who discussed the importance of focusing on the needs of AYAs with cancer.
Advertisement
The middle — an area many adolescent and young adults (AYAs) with cancer find themselves.
While their physical and emotional needs tend to be quite different, many institutions fail to focus on the specific needs of AYAs who don’t fall under either the
In this week’s episode of CURE® Talks Cancer, we spoke with a young adult who was diagnosed with
Advertisement
Related to this article
A leukemia survivor recalls how bonding with other patients helped his hospital stays go by faster and became a key part of his emotional healing.
Advertisement
Advertisement